Form 4: Verrica Pharmaceuticals Chief Medical Officer Sells Shares to Cover Tax Obligations

Gary Goldenberg, Chief Medical Officer of Verrica Pharmaceuticals, sold shares to cover statutory tax withholding obligations related to the settlement of restricted stock units.

Summary

• Gary Goldenberg, the Chief Medical Officer of Verrica Pharmaceuticals, sold shares of common stock on August 26 and 27, 2024.
• The sales were executed to cover statutory tax withholding obligations associated with the settlement of restricted stock units.
• On August 26, 2024, 9,888 shares were sold at a weighted average price of $2.66, with prices ranging from $2.53 to $2.83.
• On August 27, 2024, 3,601 shares were sold at a weighted average price of $2.46, with prices ranging from $2.40 to $2.53.
• Following these transactions, Goldenberg directly owns 94,261 shares of Verrica Pharmaceuticals common stock.

Sentiment

Score: 6

Explanation: The document reports routine stock sales to cover tax obligations, which is neutral. There is no indication of positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

Sales to cover tax obligations are a routine part of equity compensation plans and are not necessarily indicative of a negative outlook on the company.

Stakeholder Impact

• The sale of shares by a company officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates